by Josh Forsythe, on May 23, 2018
MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical genomics solutions, announced today that it has appointed Michael L. Sanderson as Chief Executive Officer and Director of the Board. In his new role, Sanderson will execute on the company’s strategy to integrate PierianDx’s unique value proposition for molecular labs into the broader precision medicine and healthcare delivery markets.
Read Storyby Josh Forsythe, on May 13, 2018
MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that it has executed a distribution agreement with ScienceVision, a leading provider of end-to-end genomic solutions in the Asia Pacific region.
Read Story
6 City Place
Creve Coeur, MO 63141
314-628-0035